Point-of-Care Molecular Diagnostics Market

Point-of-Care Molecular Diagnostics Market Size, Share, Growth Analysis, By Technology(PCR-based, Genetic Sequencing-based, Hybridization-based, Microarray-based), By Application Type(Infectious Diseases, HIV POC, Clostridium difficile POC, HBV POC), By Location(OTC, POC), By End-use(Decentralized Labs, Hospitals, Home-care, Assisted Living Health Care Facilities), By Regional(North America, Europe, Asia Pacific, Latin America) - Industry Forecast 2024-2031


Report ID: UCMIG35A2454 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Point-of-Care Molecular Diagnostics Market Insights

Market Overview:

In 2022, the global point-of-care molecular diagnostics market achieved a significant valuation of USD 7,232.2 million. Going forward, it is projected to witness a steady growth rate with a compound annual growth rate (CAGR) of 3.1% from 2023 to 2030. This growth can be attributed to several factors, including the increasing demand for rapid and accurate diagnostic tests at the point of care, advancements in technology that enable portable and user-friendly molecular diagnostic devices, and the rising prevalence of infectious diseases. Furthermore, the COVID-19 pandemic has further emphasized the importance of point-of-care molecular diagnostics in enabling timely and effective disease management. With ongoing research and development in the field, the market is expected to witness substantial expansion in the coming years.

Point-of-Care Molecular Diagnostics Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Health Care Equipment by segment aggregation, the contribution of the Health Care Equipment in Health Care Equipment & Services and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for Point-of-Care Molecular Diagnostics was estimated to be valued at US$ XX Mn in 2021.

The Point-of-Care Molecular Diagnostics Market is estimated to grow at a CAGR of XX% by 2028.

The Point-of-Care Molecular Diagnostics Market is segmented on the basis of Technology, Application Type, Location, End-use, Regional.

Based on region, the Point-of-Care Molecular Diagnostics Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Point-of-Care Molecular Diagnostics Market are Abbott, Bayer AG, F. Hoffmann-La Roche AG, Nova Biomedical, QIAGEN, Nipro Diagnostics, Danaher, Bio-Rad Laboratories, Inc., bioMérieux, Agilent Technologies, Inc., Abaxis, OraSure Technologies.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Point-of-Care Molecular Diagnostics Market

Report ID: UCMIG35A2454

$5,300
BUY NOW GET FREE SAMPLE